Researchers at Scripps Research have redesigned fentanyl at the molecular level, challenging decades-old assumptions about opioid chemistry.
RIT researchers solve multiple tissue engineering challenges by developing a novel hydrogel to host human cells and a device to 3D print bioinks safely.
If Congress fails to pass market structure legislation this year, the U.S. crypto market would not revert to the enforcement-heavy environment of 2022 and 2023, but it would remain structurally ...
TRAVIS COUNTY, Texas (KXAN) — A building at an apartment complex in Bee Cave collapsed due to a fire Monday morning, according to Lake Travis Fire Rescue. The agency said firefighting efforts were in ...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. After the ...
Ubisoft has confirmed in an interview the first details of its new Creative House structure, the cancellation of six games and the delay of seven more, and a "final" round of cuts to deliver €200 ...
In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...
But what if the biggest giveaway that a text was written by AI isn’t a word, phrase, or punctuation mark, but a particular sentence structure instead? The idea that certain rhythms of sentences might ...
The Bermuda Triangle may not be the biggest mystery of the Atlantic. In a new study published in the journal Geophysical Research Letters, scientists believe they have discovered the reason why ...
After weeks of what had been tightly buttoned talks between the parties, Senate Democrats have delivered their latest counteroffer on the crypto market structure bill, outlining a set of demands ...
Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...